Triage Survey for Psychiatry Research Eligibility
TRIAGE-Psych
1 other identifier
observational
20,000
1 country
6
Brief Summary
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 21, 2021
CompletedFirst Submitted
Initial submission to the registry
March 24, 2023
CompletedFirst Posted
Study publicly available on registry
April 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
May 20, 2026
May 1, 2026
6 years
March 24, 2023
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study
Up to 52 weeks
Secondary Outcomes (2)
The proportion of participants who enroll in industry-sponsored clinical trials
Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials
Up to 52 weeks
Interventions
Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.
Eligibility Criteria
Participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in psychiatry will be screened for clinical appropriateness for a study trial.
You may qualify if:
- Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- Participant is at least 18 years old.
You may not qualify if:
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
- Currently employed by Adams Clinical or a first-degree relative of an employee.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Adams Clinicallead
Study Sites (6)
Adams Clinical, Boston
Boston, Massachusetts, 02116, United States
Adams Clinical, Watertown
Watertown, Massachusetts, 02472, United States
Adams Clinical, Harlem
New York, New York, 10029, United States
Adams Clinical, Bronx
The Bronx, New York, 10461, United States
Adams Clinical, Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Adams Clinical, Dallas
DeSoto, Texas, 75115, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2023
First Posted
April 6, 2023
Study Start
December 21, 2021
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
May 20, 2026
Record last verified: 2026-05